カテゴリ： GlobalData, アメリカ, 企業調査

Singulex Inc：企業の製品パイプライン分析2018

◆英語タイトル：Singulex Inc - Product Pipeline Analysis, 2018 Update
◆商品コード：DATA904C5273
◆発行会社（調査会社）：GlobalData
◆発行日：2018年9月
◆ページ数：45
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD1,500 ⇒換算￥222,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD2,250 ⇒換算￥333,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Singulex Inc (Singulex) is a medical device company develops single molecule counting technology. The company provides Sgx clarity system, an in vitro diagnostics platform that provides high sensitivity next generation immunodiagnostics. Its proprietary SMC technology allows scientists and physicians in identifying the biomarkers of disease. Singulex’s SMC technology offer ultrasensitive lab testing services for facilitating proactive health management. The company also provides immunoassay kits and reagents and immunoassay systems. It offers services such as clinical lab testing, patient lab testing, wellness programs, clinical laboratory consulting and billing and client services. The company’s technology is used for medical practice or clinical diagnostics and scientific research applications. Singulex is headquartered in Alameda, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Singulex Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Singulex Inc Company Overview 6
Singulex Inc Company Snapshot 6
Singulex Inc Pipeline Products and Ongoing Clinical Trials Overview 6
Singulex Inc – Pipeline Analysis Overview 9
Singulex Inc – Key Facts 9
Singulex Inc – Major Products and Services 10
Singulex Inc Pipeline Products by Development Stage 11
Singulex Inc Ongoing Clinical Trials by Trial Status 13
Singulex Inc Pipeline Products Overview 14
Sgx Clarity cTnl Assay 14
Sgx Clarity cTnl Assay Product Overview 14
Sgx Clarity System 15
Sgx Clarity System Product Overview 15
Sgx Clarity System Clinical Trial 16
Sgx Clarity System – Companion Diagnostic Assay 17
Sgx Clarity System – Companion Diagnostic Assay Product Overview 17
Sgx Clarity System – Sepsis Rule-Out / Rule-In Test 18
Sgx Clarity System – Sepsis Rule-Out / Rule-In Test Product Overview 18
Sgx Clarity System – SIRS Rule-Out / Rule-In Test 19
Sgx Clarity System – SIRS Rule-Out / Rule-In Test Product Overview 19
Singulex POC System 20
Singulex POC System Product Overview 20
SMC Adiponectin Test 21
SMC Adiponectin Test Product Overview 21
SMC Endothelin Assay 22
SMC Endothelin Assay Product Overview 22
SMC HDL With Fractionation Assay 23
SMC HDL With Fractionation Assay Product Overview 23
SMC HDL2b Test 24
SMC HDL2b Test Product Overview 24
SMC IL-10 Assay 25
SMC IL-10 Assay Product Overview 25
SMC IL-17A Assay 26
SMC IL-17A Assay Product Overview 26
SMC IL-6 Assay 27
SMC IL-6 Assay Product Overview 27
SMC Leptin Test 28
SMC Leptin Test Product Overview 28
SMC sdLDL Assay 29
SMC sdLDL Assay Product Overview 29
SMC TNF-Alpha Assay 30
SMC TNF-Alpha Assay Product Overview 30
Ultra-Sensitive Clostridium Difficile Toxin A/B Assay 31
Ultra-Sensitive Clostridium Difficile Toxin A/B Assay Product Overview 31
Singulex Inc – Key Competitors 32
Singulex Inc – Key Employees 33
Singulex Inc – Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Joint Venture 34
Recent Developments 35
Singulex Inc, Recent Developments 35
Apr 24, 2018: Singulex Clarity C. diff toxins A/B assay in development shown to be ultrasensitive and highly specific compared with currently available testing options 35
Mar 21, 2018: Study shows cardiac troponin measurement using ultra-sensitive Singulex cTnI test can identify the presence and severity of coronary artery disease in stable, symptomatic outpatients 36
Mar 13, 2018: Study adds to understanding about utility of ultra-sensitive cardiac troponin measurement in diagnosing and predicting cardiovascular syndromes 36
Feb 28, 2018: Study shows high-sensitivity cardiac troponin I concentrations is an independent predictor of obstructive coronary artery disease in patients with suspected stable angina 37
Feb 27, 2018: PAXMAN’s scalp cooling system available at all the five highest-ranked cancer centres in the USA 38
Nov 01, 2017: Singulex announces 510(k) submission for the first ultra-sensitive cardiac troponin I (cTnI) test using Single Molecule Counting technology 38
Sep 08, 2017: Singulex Receives New, Broad Patent for Digital Detection Of Cardiac Troponin-I Or Cardiac Troponin-T For Coronary Artery Disease Rule-Out 39
Aug 01, 2017: Evaluations of the Analytical Performance of the Singulex Cardiac Troponin I Assay Used on its Single Molecule Counting Technology Platform Demonstrates Ability to Improve Cardiovascular Disease Rule-Out 39
Jun 05, 2017: Ultra-Sensitive C. Difficile Assay In Development By Singulex Demonstrates Potential To Improve Diagnosis In Pilot Studies 40
Jun 01, 2017: First ultra-sensitive cardiac troponin (cTnI) test using Single Molecule Counting technology receives CE Mark 40
Appendix 42
Methodology 42
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
Singulex Inc Pipeline Products and Ongoing Clinical Trials Overview 6
Singulex Inc Pipeline Products by Equipment Type 7
Singulex Inc Pipeline Products by Indication 8
Singulex Inc Ongoing Clinical Trials by Trial Status 8
Singulex Inc, Key Facts 9
Singulex Inc, Major Products and Services 10
Singulex Inc Number of Pipeline Products by Development Stage 11
Singulex Inc Pipeline Products Summary by Development Stage 12
Singulex Inc Ongoing Clinical Trials by Trial Status 13
Singulex Inc Ongoing Clinical Trials Summary 13
Sgx Clarity cTnl Assay - Product Status 14
Sgx Clarity cTnl Assay - Product Description 14
Sgx Clarity System - Product Status 15
Sgx Clarity System - Product Description 15
Sgx Clarity System - Aiming Towards Evidence Based Interpretation of Cardiac Biomarkers in Patients Presenting with Chest Pain (WESTCOR Study) 16
Sgx Clarity System - Companion Diagnostic Assay - Product Status 17
Sgx Clarity System - Companion Diagnostic Assay - Product Description 17
Sgx Clarity System - Sepsis Rule-Out / Rule-In Test - Product Status 18
Sgx Clarity System - Sepsis Rule-Out / Rule-In Test - Product Description 18
Sgx Clarity System - SIRS Rule-Out / Rule-In Test - Product Status 19
Sgx Clarity System - SIRS Rule-Out / Rule-In Test - Product Description 19
Singulex POC System - Product Status 20
Singulex POC System - Product Description 20
SMC Adiponectin Test - Product Status 21
SMC Adiponectin Test - Product Description 21
SMC Endothelin Assay - Product Status 22
SMC Endothelin Assay - Product Description 22
SMC HDL With Fractionation Assay - Product Status 23
SMC HDL With Fractionation Assay - Product Description 23
SMC HDL2b Test - Product Status 24
SMC HDL2b Test - Product Description 24
SMC IL-10 Assay - Product Status 25
SMC IL-10 Assay - Product Description 25
SMC IL-17A Assay - Product Status 26
SMC IL-17A Assay - Product Description 26
SMC IL-6 Assay - Product Status 27
SMC IL-6 Assay - Product Description 27
SMC Leptin Test - Product Status 28
SMC Leptin Test - Product Description 28
SMC sdLDL Assay - Product Status 29
SMC sdLDL Assay - Product Description 29
SMC TNF-Alpha Assay - Product Status 30
SMC TNF-Alpha Assay - Product Description 30
Ultra-Sensitive Clostridium Difficile Toxin A/B Assay - Product Status 31
Ultra-Sensitive Clostridium Difficile Toxin A/B Assay - Product Description 31
Singulex Inc, Key Employees 33
Singulex Inc, Joint Venture 34
Glossary 44

List of Figures
Singulex Inc Pipeline Products by Equipment Type 7
Singulex Inc Pipeline Products by Development Stage 11
Singulex Inc Ongoing Clinical Trials by Trial Status 13

★海外企業調査レポート[Singulex Inc：企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • PGS ASA (PGS)：企業の財務・戦略的SWOT分析
    PGS ASA (PGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Odebrecht S.A.：戦略・SWOT・企業財務分析
    Odebrecht S.A. - Strategy, SWOT and Corporate Finance Report Summary Odebrecht S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Myriad Genetics Inc (MYGN)：製薬・医療：M&Aディール及び事業提携情報
    Summary Myriad Genetics Inc (Myriad) is a specialty molecular diagnostic company, which discovers and commercializes molecular diagnostic tests, personalized medicine and services for major diseases. The company’s product portfolio includes molecular diagnostic testing products that analyze genes, t …
  • AUDI AG：企業の戦略・SWOT・財務分析
    AUDI AG - Strategy, SWOT and Corporate Finance Report Summary AUDI AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Shenzhen Kaifa Technology Co Ltd (000021)：企業の財務・戦略的SWOT分析
    Shenzhen Kaifa Technology Co Ltd (000021) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Abcam Plc (ABC)：製薬・医療：M&Aディール及び事業提携情報
    Summary Abcam Plc (Abcam) is a supplier of life science research tools for analysis of living cells at molecular level to understand a wide range of disease conditions. The company develops and markets antibodies and other related products. Its product portfolio includes primary antibodies, secondar …
  • GliaCure Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary GliaCure Inc (GliaCure) is a developer of novel therapies for neurological and neuropsychiatric disorders. The company uses glia as an untapped resource for drug discovery, which controls the brain function in health and disease. It develops small molecule pharmaceuticals for the treatment o …
  • Valora Holding AG (VALN)：企業の財務・戦略的SWOT分析
    Valora Holding AG (VALN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Jungbunzlauer Suisse AG：企業の戦略・SWOT・財務情報
    Jungbunzlauer Suisse AG - Strategy, SWOT and Corporate Finance Report Summary Jungbunzlauer Suisse AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • StemBioSys Inc-製薬・医療分野：企業M&A・提携分析
    Summary StemBioSys Inc (StemBioSys) is a biomedical company that concentrates on isolation, expansion and delivery of specialized adult stem cells. The company has developed high performance microenvironment for treating human diseases. Its HPME is an advanced stem cell culture system that creates n …
  • Bank of Ningbo Co. Ltd.：企業の戦略・SWOT・財務情報
    Bank of Ningbo Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Bank of Ningbo Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Lennox International Inc.：企業の戦略・SWOT・財務情報
    Lennox International Inc. - Strategy, SWOT and Corporate Finance Report Summary Lennox International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Posco Daewoo Corp (047050)：企業の財務・戦略的SWOT分析
    Posco Daewoo Corp (047050) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196)：企業の財務・戦略的SWOT分析
    Summary Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company’s pharmaceutical products include metabolism …
  • Interim HealthCare Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Interim HealthCare Inc (IHC), formerly Medical Personnel Pool Inc, is a healthcare service provider that offers home care and home health care services. The center provides senior care, pediatric nursing and physical, occupational and speech therapy. Its specialized homecare services include …
  • Escorts Ltd：企業の戦略・SWOT・財務情報
    Escorts Ltd - Strategy, SWOT and Corporate Finance Report Summary Escorts Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • iKang Healthcare Group Inc：企業の戦略・SWOT・財務情報
    iKang Healthcare Group Inc - Strategy, SWOT and Corporate Finance Report Summary iKang Healthcare Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • H. Lundbeck AS (LUN)-製薬・医療分野：企業M&A・提携分析
    Summary H. Lundbeck A/S (Lundbeck), a subsidiary of The Lundbeck Foundation carries out the research, development, manufacturing and marketing of pharmaceuticals for the treatment of the central nervous system (CNS) related diseases including psychiatric and neurological disorders. Its products are …
  • Chemring Energetics UK Ltd：企業の戦略・SWOT・財務情報
    Chemring Energetics UK Ltd - Strategy, SWOT and Corporate Finance Report Summary Chemring Energetics UK Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Globo Comunicacao e Participacoes S.A.：企業の戦略的SWOT分析
    Globo Comunicacao e Participacoes S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆